Cases
-
Latest cases
Court Rejects Damage Claims Against Compass Lexecon Client American Airlines in Novel ERISA Class Action
Compass Lexecon Successfully Supports Experts in Demonstrating Lack of Financial Losses
-
Latest cases
Tribunal Grants Six-Year Concession Extension to Lima Expresa
-
Latest cases
Meta Antitrust Suit Dismissed
-
Latest cases
How to value flexible operation in Energy-Intensive Industries: Technical and economic assessment in the EU
-
Latest cases
Major Banks Granted Summary Judgment in LIBOR-Based Antitrust Litigation Case
Compass Lexecon Expert Professor Dennis Carlton Testifies Successfully for JPMorgan Chase
-
Latest cases
Thermo Fisher obtains clearance for its $4.1 billion acquisition of Solventum’s Purification and Filtration Business
-
Latest cases
Compass Lexecon advises Energie Nederland on Resource Adequacy and the future design of the Dutch electricity market
-
Latest cases
Compass Lexecon Affiliate Professor B. Douglas Bernheim Testifies Successfully in Amex Antitrust Jury Trial
Showing 1–16 of 67 results
-
18 Sept 2025
Compass Lexecon advised Thermo Fisher Scientific (‘Thermo Fisher’) and Solventum in the context of Thermo Fisher’s acquisition of Solventum’s Purification and Filtration business in the… -
11 Aug 2025
On August 7, 2025, UnitedHealth Group (UHG) settled its litigation with the U.S. Department of Justice and several State Co-Plaintiffs, clearing the path to close its $3.3 billion acquisition of… -
21 Jul 2025
Plaintiffs alleged that AbbVie, its chief executive officer, and former chief financial officer fraudulently misled investors by concealing that the company had violated the federal Anti-Kickback… -
28 Apr 2025
A new study of the pharmacy benefit manager (PBM) industry was released by Professor Dennis Carlton, one of the leading industrial organization economists in the country and a former Deputy… -
22 Apr 2025
U.S. District Court Judge Paul S. Diamond for the Eastern District of Pennsylvania granted summary judgment mid-trial in favor of Compass Lexecon’s client DePuy Synthes in a patent infringement… -
On September 20, 2024, Johnson & Johnson subsidiary Red River Talc (RRT) filed a prepackaged bankruptcy to resolve the tens of thousands of pending and future personal injury claims alleging…
-
03 Apr 2025
Co-Diagnostics retained Compass Lexecon and Senior Consultant Professor Allen Ferrell to rebut the Plaintiff’s expert’s opinions on loss causation and damages. -
20 Nov 2024
A jury ruled in favor of Compass Lexecon’s client, the City of Baltimore (the City), in a trial against several pharmaceutical distributors (Defendants). The jury ruled that the Defendants’… -
09 Oct 2024
Dennis W. Carlton, Mary Coleman, Nauman Ilias, Theresa Sullivan, and Nathan Wilson conducted a study, commissioned by Caremark, Express Scripts, and Optum Rx, that focuses on the role of pharmacy… -
13 Aug 2024
On August 1, 2024, AbbVie completed its $8.7 billion acquisition of Cerevel Therapeutics. The deal closed after a merger review by the U.S. Federal Trade Commission. A Compass Lexecon team led… -
03 Apr 2024
Compass Lexecon’s client Express Scripts defeated a motion for certification of putative classes of direct and indirect purchasers of the specialty drug Acthar. -
08 Jan 2024
On December 14, 2023, Pfizer completed its $43 billion acquisition of Seagen – the largest M&A deal in biopharma since 2019. The deal closed after merger reviews by competition authorities around… -
13 Sept 2023
Compass Lexecon worked closely with the merging parties on this matter, starting with a team advising Horizon on the merger (led by Compass Lexecon expert Mark Israel) and proceeding to the… -
22 Mar 2022
Dr. Nathan Wilson and Compass Lexecon were retained by Riverside Health System to provide economic analysis in support of their plan to build a new hospital in Isle of Wight County, Virginia. -
14 Mar 2022
On March 11, 2022, a jury in California delivered a unanimous verdict in favor of Compass Lexecon’s client Sutter Health in Sidibe et. al, v. Sutter Health, a Federal class action antitrust case… -
20 Dec 2021
Compass Lexecon provided economic advice and analysis in the $17 billion global acquisition of PPD, Inc by Thermo Fisher Scientific Inc. PPD is a contract research organisation and a lab service…
Our professionals
Compass Lexecon’s staff includes more than 700 employees, including professional consultants, analysts, and practice support personnel that span 25 offices across the globe.
